Safety and Efficacy of Abicipar Pegol in Participants With Neovascular Age-related Macular Degeneration
Study Identifier
150998-006
CT.gov Identifier
EudraCT Identifier
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete
Results Available
Statistical Analysis Plan
Available Language(s): English
Protocol
Available Language(s): English
Study Details
Medical Condition
Study Drug
Phase
Phase 3
Sex
Female & Male
Age
50+ years
Protocol Summary
This is a safety and efficacy study of abicipar pegol in participants with neovascular age-related macular degeneration.
Study Locations
Location
Status
Location
Eye Foundation Hospital
Birmingham, Alabama, United States, 35233
Status
Not applicable
Location
Retinal Consultants of Arizona
Gilbert, Arizona, United States, 85296
Status
Not applicable
Location
Barnet Dulaney Perkins Eye Center - Phoenix
Phoenix, Arizona, United States, 85016-4701
Status
Not applicable
Location
Retina Centers, PC
Tucson, Arizona, United States, 85704
Status
Not applicable
Location
Northwest Arkansas Retina Associates
Springdale, Arkansas, United States, 72762
Status
Not applicable
Location
Win Retina
Arcadia, California, United States, 91006
Status
Not applicable
Showing {first} - {last} of {total} Results